Read the latest from RareKids-CAN.
Dr. Thierry Lacaze, Nominated Principal Investigator, and Breanne Stewart, Network Director, represented RareKids-CAN at the in-person ERDERA workshop held in Riga, Latvia on…
Key Takeaway:Virus-specific T cells (VSTs) used to successfully treat a newborn with a life-threatening CMV infectionRareKids-CAN and the Riddell Centre…
Earlier this month, the RareKids-CAN community came together to connect, collaborate, and learn—both in person in Ottawa and virtually from…
This past Rare Disease Day on February 28, 2025, our team came together to raise awareness, share patient and family…
RareKids-CAN is thrilled to congratulate INFORM RARE’s Youth Advisory Group for placing first in the video category of the IHDCYH…
On 27 December 2024, ECRIN and MICYRN signed a Memorandum of Understanding (MoU) with the intention of better aligning their…
RareKids-CAN is thrilled to extend our happiest congratulations to Maureen Smith on her new position on the Board of Directors…
We are happy to share an update from Andrea and her son Jakob, one of our incredible family partners on…
The Health Canada Relations and Advocacy Sub-Platform of RareKids-CAN and the Maternal Infant Child and Youth Research Network (MICYRN), in…
